<DOC>
	<DOCNO>NCT00043836</DOCNO>
	<brief_summary>The purpose study test hypothesis treatment oral ALT-711 twice daily 16 week improve aortic distensibility , exercise tolerance , quality life elderly patient isolate diastolic heart failure ( DHF ) , improvement exercise tolerance correlate improvement aortic distensibility .</brief_summary>
	<brief_title>The DIAMOND Study : Distensibility Improvement And Remodeling Diastolic Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Dyspnea</mesh_term>
	<mesh_term>Heart Failure , Diastolic</mesh_term>
	<mesh_term>Pulmonary Edema</mesh_term>
	<criteria>Inclusion Criteria 1 . Men woman ≥ 60 year age . 2 . Diagnosis congestive heart failure one follow criterion : Heart Failure Clinical Score ≥ 3 base NHANESI criterion and/or history either acute pulmonary edema occurrence 2 follow subsequent improvement diuretic therapy identifiable cause : dyspnea exertion , paroxysmal nocturnal dyspnea , orthopnea , systemic edema , exertional fatigue . 3 . Left ventricular ejection fraction ≥ 50 % base baseline Doppler echocardiography test . 4 . Ability provide write informed consent . 5 . Ability comply procedure specify study protocol . Exclusion Criteria 1 . Valvular heart disease primary etiology congestive heart failure . 2 . Significant change cardiovascular medication ( ) &lt; 3 week prior baseline visit . 3 . Uncontrolled hypertension . 4 . History stroke , sequelae transient ischemic attack ( TIA ) , reversible ischemic neurologic defect ( RIND ) , stroke , within last 12 month prior entry study . 5 . Cancer noncardiovascular condition life expectancy le 2 year . 6 . Significant anemia define hemoglobin &lt; 11 gm/dL . 7 . Significant renal insufficiency define serum creatinine &gt; 2.5 mg/dL . 8 . Significant hepatic insufficiency define SGPT ( ALT ) SGOT ( AST ) &gt; 2.5 time upper limit normal . 9 . Psychiatric disease ( include uncontrolled major psychosis , depression , dementia , personality disorder ) additional condition ( ) , investigator 's opinion , would prohibit patient complete study , best interest patient . 10 . Presence history drug alcohol abuse . 11 . Prior exposure ALT711 use investigational drug within 30 day prior screen . 12 . Known seropositivity HIV hepatitis C , presence hepatitis B surface antigen . 13 . Severe COPD require recurrent oral steroid , oxygen home one inhaler . 14 . Baseline echocardiogram demonstrate presence leave ventricular ejection fraction &lt; 50 % . 15 . Unstable uncontrolled myocardial ischemia , wall abnormality . 16 . Screening Familiarization Exercise Test demonstrate presence follow finding : evidence significant ischemia ( consist ECG find &gt; 1 mm flat ST depression confirm echocardiogram wall motion , wall motion abnormality decrease global contractility echocardiogram , inability continue exercise due significant chest leg pain reason exhaustion/fatigue/dyspnea , exercise SBP &gt; 240 mm Hg , DBP &gt; 110 mmHg , unstable hemodynamics rhythm , unwilling unable complete test adequately . 17 . Any contraindication magnetic resonance image include limited indwelling metalcontaining prosthesis ( orthopedic , valvular , ) , pacemaker defibrillator , history weld occupation ( ocular metal debris ) , uncontrollable claustrophobia .</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2007</verification_date>
	<keyword>ejection fraction</keyword>
	<keyword>exercise tolerance</keyword>
	<keyword>heart failure , congestive</keyword>
	<keyword>quality life</keyword>
</DOC>